Which antibiotic strategy saves more lives from enterococcus blood infection?
NCT ID NCT07299539
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at 700 adults with Enterococcus faecalis bloodstream infection, a condition with a 15-25% death rate. Researchers compare patients who received one antibiotic versus a combination of antibiotics to see which approach reduces deaths and complications. The goal is to provide clear guidance for doctors treating this infection.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
antibiotic therapy (monotherapy vs combination therapy)
What this could lead to
If it works, this could clarify the best antibiotic approach for a serious bloodstream infection, potentially lowering death rates and preventing heart complications.
What could go wrong
This is a retrospective observational study, not a controlled trial, so results may be influenced by other factors. The findings may not apply to all patients or settings.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ENTEROCOCCUS FAECALIS BACTEREMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Service des Maladies Infectieuses et Tropicales - CHU de Strasbourg - France
RECRUITINGStrasbourg, 67091, France
Contact
Contact
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact